ARTICLE | Company News
Nycomed sales and marketing update
September 6, 2010 7:00 AM UTC
Nycomed launched Daxas roflumilast in Germany for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis in adult patients with a history of ...